Tiep Le
- Immunology top 2%
- Immunotherapy and Immune Responses 2
- Cancer Research top 2%
- Molecular Biology top 5%
- Cell death mechanisms and regulation 4
- Viral Infectious Diseases and Gene Expression in Insects 2
- Oncology top 5%
- CAR-T cell therapy research 3
- HER2/EGFR in Cancer Research 2
- Biotechnology top 2%
- Cancer Research and Treatments 2
-
- Virus-based gene therapy research 4
-
- Herpesvirus Infections and Treatments 3
Tiep Le
14 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 1.1k
- Cancer Research 738
- Molecular Biology 2.3k
- Oncology 824
- Biotechnology 215
Countries citing papers authored by Tiep Le
This map shows the geographic impact of Tiep Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiep Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiep Le more than expected).
Fields of papers citing papers by Tiep Le
This network shows the impact of papers produced by Tiep Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiep Le. The network helps show where Tiep Le may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tiep Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2019 | 2 | |
| 4 | 2017 | 81 | |
| 5 | 2016 | 31 | |
| 6 | 2015 | 3 | |
| 7 | 2015 | 4 | |
| 8 | 2013 | 4 | |
| 9 | 2007 | 32 | |
| 10 | 2002 | 146 | |
| 11 | 2002 | 59 | |
| 12 | 2002 | 111 | |
| 13 | Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivobreakdown → | 1999 | 2158 |
| 14 | Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. | 1999 | 223 |
| 15 | 1996 | 42 |
About Tiep Le
Tiep Le is a scholar working on Oncology, Immunology, Biotechnology, Genetics and Cancer Research, having authored 15 papers that have together received 2.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Cell death mechanisms and regulation (4 papers), CAR-T cell therapy research (3 papers), Herpesvirus Infections and Treatments (3 papers), Immunotherapy and Immune Responses (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Cancer Research and Treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (738 citations), Molecular Biology (2.3k citations), Oncology (824 citations) and Biotechnology (215 citations). Tiep Le has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Brian Gliniak, Jon Jones, Robert E. Miller, David H. Lynch, JoAnn C. L. Schuh, Marek Kubin, Raymond G. Goodwin, Thomas S. Griffith, Charles T. Rauch and Henning Walczak. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Nature Medicine and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.